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Abstract
Eosinophilic esophagitis (EoE) is currently defined as an immune-mediated chronic esophageal
disorder that is diagnosed using both clinical and pathologic information. A series of consensus
diagnostic guidelines for EoE have brought a measure of consistency to the field, but in practice
the diagnosis of EoE can be challenging. Typical clinical symptoms of EoE, including dysphagia,
heartburn, and chest pain, can overlap with gastroesophageal reflux disease (GERD), which itself
is a common indication for performing endoscopic evaluation. The endoscopic findings of EoE,
such as esophageal rings, strictures, linear furrows, and white exudates are not specific.
Esophageal eosinophilia, the histologic hallmark of EoE, is also not pathognomonic and can be
seen in a range of conditions. Further complicating the diagnosis of EoE is the newly recognized
entity of proton pump inhibitor-responsive esophageal eosinophilia (PPI-REE), a condition that
must be excluded prior to confirming a diagnosis of EoE. This paper will review the current
diagnostic criteria for EoE, and discuss multiple clinical, endoscopic, and histologic pitfalls in
making the diagnosis of EoE.
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Introduction
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus that
has become widely recognized as a major cause of upper gastrointestinal morbidity [1]. It is
currently defined as an immune/allergy-mediated clinicopathologic condition, and is
characterized both by symptoms of esophageal dysfunction and a prominent eosinophilic
infiltrate in the esophageal mucosa [2]. Despite the publication of a series of guidelines over
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the past 6 years [2-4], diagnosis of EoE is not straightforward and challenges are frequently
encountered [5]. The purpose of this paper is to review the current diagnostic guidelines for
EoE, and then to present clinical, endoscopic, and histologic pitfalls that are encountered
when diagnosing EoE. Clinical pitfalls include inadequately considering the differential
diagnosis of esophageal eosinophilia, distinguishing gastroesophageal reflux disease
(GERD) and EoE, and appropriately excluding the newly recognized entity of proton pump
inhibitor-responsive esophageal eosinophilia (PPI-REE). Endoscopic pitfalls include the
reliability of typical findings of EoE and inadequate esophageal biopsy protocols. Histologic
pitfalls include variability in diagnostic criteria and in eosinophil count quantification.
Techniques and emerging technologies to facilitate diagnosis of EoE are addressed in detail
in other manuscripts in this issue of the journal.
EoE diagnostic guidelines
While the first case report of EoE was published more than 3 decades ago [6] and case series
describing the disease as it is currently recognized were published about 20 years ago [7-9],
the first guidelines for diagnosis were only published in 2007 [3]. These defined EoE as a
clinicopathologic disorder requiring symptoms of esophageal dysfunction and an esophageal
biopsy with at least 15 eosinophils per high-power field (eos/hpf), but in the absence of
GERD. The guidelines were updated in 2011 by a large consensus committee, and while the
symptom and histology requirements were unchanged, there was no longer a requirement to
specifically exclude GERD [2]. Instead, the complex interplay between GERD and EoE was
acknowledged (see below), and there was a requirement to exclude PPI-REE, a newly
recognized cause of esophageal eosinophilia. Most recently, clinical guidelines from the
American College of Gastroenterology reinforce the 2011 diagnostic guidelines while
emphasizing the importance of excluding secondary causes of esophageal eosinophilia [4].
Despite the publication of these guidelines, practice pattern surveys indicate that at most
one-third of gastroenterologists and allergists followed the 2007 guidelines [10, 11].
Similarly, only one-third of publications have strictly adhered to the guidelines [12]. These
results may be explained, in part, by challenges that are embedded in each of the diagnostic
criteria. In practice, it is common to encounter clinical, endoscopic, and histologic pitfalls
when attempting the diagnosis EoE. A major reason for this is that there is no single clinical,
endoscopic, or histologic sign that is pathognomic for EoE, and the entire clinical picture
must be considered before a diagnosis can be made.
Clinical pitfalls in EoE diagnosis
The first pitfall encountered in EoE diagnosis is failing to consider the differential diagnosis
of esophageal eosinophilia. The finding of eosinophils on esophageal biopsy in isolation
cannot be equated to a diagnosis of EoE. There are a number of gastrointestinal and
systemic conditions that can cause eosinophils to infiltrate the esophageal mucosa. These
include: other eosinophilic gastrointestinal disorders such as eosinophilic gastroenteritis,
Crohn's disease with esophageal involvement, pill esophagitis, connective tissue diseases,
infections (fungal, viral, and parasitic), drug reactions, hypereosinophilic syndrome,
achalasia, graft versus host disease, and others [2, 4]. Most of these can be excluded with a
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thorough history, physical exam, and basic laboratory tests. However, the two conditions
that EoE most frequently must be differentiated from are GERD and PPI-REE.
GERD is a common cause of upper GI symptoms such as heartburn, dysphagia, and chest
pain, and these can overlap with EoE symptoms. In case-control studies, there are no single
symptoms or endoscopic findings that can differentiate EoE from GERD in isolation
[13-15]. There is also substantial histologic overlap, with esophageal eosinophilia, basal
zone hyperplasia, and spongiosis seen in both EoE and GERD [13, 14]. Even very high
esophageal eosinophil counts cannot distinguish the two conditions. As shown in a
retrospective review of esophageal biopsies at a GERD referral center [16], eosinophil
counts for GERD and EoE patients were markedly elevated and overlapped substantially;
the EoE group had 51-204 eos/hpf and the GERD group had 20-168 eos/hpf. In addition to
this clinical overlap, the relationship between GERD and EoE can be even more
complicated. GERD and acid exposure can lead to esophageal eosinophilia, GERD and EoE
can independently coexist, it is possible that EoE could lead to reflux (via altered motility or
mucosal function caused by inflammation), and it is possible that reflux could lead to EoE
(via increased allergen presentation due to injured mucosa) [17].
Complicating the issue further is PPI-REE, the term used to describe esophageal
eosinophilia that responds to proton pump inhibitor therapy. This phenomenon was first
reported in a case series of three pediatric patients who presented with dysphagia, food
impaction, and vomiting, were found to have esophageal eosinophilia suspicious for EoE,
and had resolution of symptoms and normalization of esophageal biopsies after treatment
with PPI [18]. Since then, a number of prospective and retrospective studies in both children
and adults have reported a PPI-response rate between 33% and 74% in subjects with ≥ 15
eos/hpf on esophageal biopsy [19-28]. Interestingly, the mechanism of this response might
be an acid-independent anti-inflammatory effect of the PPIs themselves. Recent data suggest
that PPIs can inhibit IL-13 and IL-4 induced eotaxin-3 secretion from esophageal epithelial
cells in the absence of acid [29, 30].
To avoid clinical pitfalls in EoE diagnosis, it is important to fully consider the differential
diagnosis of esophageal eosinophilia. GERD and PPI-REE will be the two most common
alternatives to EoE when eosinophils are found on esophageal biopsy. As of yet, it is unclear
whether PPI-REE represents an independent condition, a sub-type of GERD, a sub-
phenotype of EoE, or potentially all three. However, because of the high rates of response to
PPIs, EoE currently cannot be diagnosed without a formal PPI trial [2, 4].
Endoscopic pitfalls in EoE diagnosis
Endoscopic evaluation in patients with suspected EoE is used to evaluate for signs of EoE,
for other alternative explanations for symptoms, and to obtain esophageal biopsies [2, 4].
Endoscopic pitfalls related to EoE diagnosis include failing to recognize the findings of EoE
and not obtaining adequate esophageal biopsy samples. The typical endoscopic findings of
EoE have been well-described and include: esophageal rings, narrowing, or strictures; linear
furrows; white plaques or exudates; decreased vasculature, pallor or edema; and mucosal
fragility, also termed crêpe-paper mucosa [2, 3, 31-34]. However, in a small proportion of
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subjects (less than 5-10%), the esophageal mucosa may appear normal, and the diagnosis
will be missed if biopsies are not obtained [35, 36].
While the above endoscopic findings are common, they are not universal and do not fully
differentiate EoE from other conditions such as GERD and PPI-REE. In a meta-analysis of
100 studies assessing more than 4600 subjects with EoE and more than 2700 non-EoE
controls [36], the prevalence of individual EoE endoscopic findings varied substantially and
were not universal. For example, esophageal rings were seen in 44%, linear furrows in 48%,
white plaques in 27%, and decreased vascularity in 41%. However, rings and strictures were
more common in adults, linear furrows and decreased vascularity were more common in
children, and all findings were more common in prospective studies where at least one
endoscopic abnormality was observed in 93% of subjects. This study also showed that the
sensitivity and specificity of these findings were not sufficient for diagnosis of EoE alone. In
addition to this, other studies have shown that there can be substantial inter- and intra-
observer variability in recognition of endoscopic findings of EoE [37]. To address this
variability, a new endoscopic classification system, termed the EoE Endoscopic Reference
Score (EREFS) has recently been validated for identification of exudates, rings, edema,
furrows, and strictures found in the esophagus of patients with EoE [38]. The hope is with
use of this system and its accompanying atlas, recognition and reporting of endoscopic
findings of EoE will become more standardized.
Because the endoscopic findings associated with EoE are not pathognomonic, it is crucial to
obtain esophageal biopsies in all patients with suspected EoE regardless of the endoscopic
appearance. However, there has been substantial variation in biopsy protocols both in the
literature and in reported practice pattern surveys [10, 35]. This is problematic because the
eosinophilic infiltration in EoE can be patchy, so if the esophagus is insufficiently sampled,
the diagnosis can be missed. For example, levels of esophageal eosinophilia can vary widely
not only throughout locations in the esophagus, but also within biopsies themselves [39-41].
In two important papers, it has been clearly shown that increasing the number of biopsies
increases the diagnostic sensitivity, which is maximized after at least 5 biopsies are taken
[41, 42]. The current guidelines recommend at least 2-4 biopsies from at least 2 different
locations (ie proximal and distal) in the esophagus [2, 4].
To avoid endoscopic pitfalls in EoE diagnosis, it is important to understand that the “classic”
endoscopic findings of EoE are common, but not universal and not specific to EoE. In
addition, use of a newly validated endoscopic classification system will help to standardize
reporting and reliability of endoscopic findings. However, regardless of the endoscopic
appearance, esophageal biopsies should be obtained to assess for esophageal eosinophilia.
The current recommendation is that at least 2-4 biopsies should be taking from both the
proximal and distal esophagus to maximize the sensitivity for diagnosing EoE.
Histologic pitfalls in EoE diagnosis
After esophageal biopsies are obtained, thorough and accurate pathologic assessment is
required. Pitfalls of histologic assessment include variability in diagnostic criteria and in
eosinophil count quantification. Prior to the publication of the 2007 guidelines, there was
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substantial variability in diagnostic thresholds of esophageal eosinophilia reported
throughout the literature, with 10 different values used (ranging from 5 to 30 eos/hpf), and
with more than one-third of studies not reporting an EoE disease definition [35]. After
adoption of a cut-point of 15 eos/hpf [3], there was less variability in the literature and in
practice, though several cut points (ranging from 15 to 30 eos/hpf) are still frequently used
[10, 12]. This variability is compounded because different microscopes have different high
power field (hpf) areas [35]. This means that for a constant eosinophil density (measured in
eos/mm2 rather than eos/hpf), a microscope with a small field would yield a lower
eosinophil count, while one with a larger field would find a higher count. Depending on the
cut-point used for diagnosis, a patient may or may not be histologically classified as EoE
based solely on the microscope field size, rather than on the underlying density of
esophageal eosinophilia. For this reason, in the future it may be desirable to report
eosinophil density (eos/mm2) rather than the eosinophil count (eos/hpf).
In additional to this variabily by microscopy field, a number of other issues must be
considered in order to determine the esophageal eosinophil count. For example, where in the
biopsy specimen should the pathologist make the eosinophil count? Should the maximum
number of eosinophils be quantified in any one hpf, should the total number in the entire
specimen be counted, or should the mean value, recently termed the eosinophil load [43], be
calculated from assessment of multiple hpfs throughout the sample? Typically, the peak
number of eosinophils has been traditionally reported [2]. Additionally, a standardized
approach for determining maximum eosinophil counts using digitized biopsy slides has been
validated and has excellent inter- and intra-observer reliability between pathologists [44].
To avoid histologic pitfalls in the diagnosis of EoE, it is recommended that a diagnostic
threshold of 15 eos/hpf be used in clinical practice. However, it is important to be cognizant
that the count will depend on the size of the microscope high power field, so understanding
how a collaborating pathologist quantifies eosinophils is key in order to interpret the results.
Standard practice is to report the peak eosinophil count, but consideration could be given to
following a validated eosinophil count quantification protocol.
Conclusions
The publication and updating of consensus guidelines for EoE has served to standardize the
requirements for diagnosis of EoE. EoE is a clinicopathologic condition which is diagnosed
when symptoms of esophageal dysfunction (such as dysphagia, food impaction, chest pain,
or heartburn) are present in the setting of esophageal eosinophilia (≥ 15 eos/hpf), but in the
absence of competing causes of esophageal eosinophilia [2-4]. However, diagnosis of EoE is
not always straightforward. A major reason for this is that there is no single clinical,
endoscopic, or histologic sign that is pathognomic for EoE, and the entire clinical picture
must be considered before a diagnosis can be made. At each stage, pitfalls are encountered
(Figure 1). Clinically, the differential diagnosis of esophageal eosinophilia must be fully
considered, and in particular GERD and EoE must be distinguished and PPI-REE must be
excluded. Endoscopically, typical findings of EoE should be recognized, but adequate
numbers of esophageal biopsies must be obtained from at least two esophageal locations
regardless of the endoscopic appearance, as tissue samples are currently required to make
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the diagnosis. Histologically, the peak eosinophil count should be determined, with the
recognition that the absolute count might vary by pathologist based on the high-power field
size of a given microscope. Knowledge of these pitfalls allows the practitioner to avoid
making errors in diagnosis, decrease diagnostic delay, and prescribe treatments for EoE to
those who will most benefit from them. Given that the field is rapidly advancing, it is likely
that novel techniques will change the paradigm for diagnosis of EoE in the future, and will
minimize diagnostic pitfalls.
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This figure outlines the clinical, endoscopic, and histologic pitfalls in diagnosing EoE. When
EoE is suspected clinically and initially endoscopy shows at least 15 eos/hpf, EoE is still not
yet diagnosed. The differential diagnosis of esophageal eosinophilia must be fully
considered, and in particular GERD and EoE must be distinguished and PPI-REE must be
excluded. After a PPI trial, a repeat endoscopy is required. Endoscopically, typical findings
of EoE should be recognized but these are not always specific for EoE. Additionally,
adequate numbers of esophageal biopsies must be obtained from at least two esophageal
locations regardless of the endoscopic appearance. Histologically, the peak eosinophil count
should be determined, with the recognition that the absolute count might vary by pathologist
based on the high-power field size of a given microscope.
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